R H Behrens, J A Roberts. Show Affiliations »
Abstract
Mesh: See more » Cost-Benefit AnalysisHepatitis A/prevention & controlHepatitis A VaccinesHepatitis A Virus, Human/immunologyHumansTravelVaccination/economicsViral Hepatitis Vaccines/economics
Substances: See more » Hepatitis A VaccinesViral Hepatitis Vaccines
Year: 1995 PMID: 7888915 PMCID: PMC2548908 DOI: 10.1136/bmj.310.6978.533a
Source DB: PubMed Journal: BMJ ISSN: 0959-8138